The DOI matches its Crossref record.
The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif
Abstract
The adapter Grb2 is an important mediator of normal cell proliferation and oncogenic signal transduction events. It consists of a central SH2 domain flanked by two SH3 domains. While the binding specificities of the Grb2 SH2 and N-terminal SH3 domain [Grb2 SH3(N)] have been studied in detail, binding properties of the Grb2 SH3(C) domain remained poorly defined. Gab1, a receptor tyrosine kinase substrate which associates with Grb2 and the c-Met receptor, was previously shown to bind Grb2 via a region which lacks a Grb2 SH3(N)-typical motif (P-x-x-P-x-R). Precipitation experiments with the domains of Grb2 show now that Gab1 can bind stably to the Grb2 SH3(C) domain. For further analyses, Gab1 mutants were generated by PCR to test in vivo residues thought to be crucial for Grb2 SH3(C) binding. The Grb2 SH3(C) binding region of Gab1 has significant homology to a region of the adapter protein SLP-76. Peptides corresponding to epitopes SLP-76, Gab1, SoS and other proteins with related sequences, as well as mutant peptides were synthesized and analysed by tryptophan-fluorescence spectrometry and by in vitro competition experiments. These experiments define a 13 amino acid sequence with the unusual consensus motif P-x-x-x-R-x-x-K-P as required for a stable binding to the SH3(C) domain of Grb2. Additional analyses point to a distinct binding specificity of the Grb2-homologous adapter protein Mona (Gads), indicating that the proteins of the Grb2 adapter family may have partially overla…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A subfamily of SH3 domains binds atypical peptide ligands centered around a consensus RXXK peptide motif.
“We and others have previously reported a subfamily of SH3 domains that bind to atypical peptide ligands centered around a consensus RXXK peptide motif (19 -21, 43-46).”
From Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex (2010) · cites this paper as [45]
We and others have previously reported two motifs in USP8 that interact with atypical SH3 domains of proteins belonging to the Grb2 and STAM adaptor families.
“We and others have previously reported two motifs in USP8 that interact with atypical SH3 domains of proteins belonging to the Grb2 and STAM adaptor families (19,45,51).”
From Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex (2010) · cites this paper as [45]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 71
- Asada H, Ishii N, Sasaki Y, Endo K, Kasai H, Tanaka N, Takeshita T, Tsuchiya S, Konno T and Sugamura K. . 1999 J. Exp. Med. 189: 1383–1390. · DOI
- Bourette RP, Arnaud S, Myles GM, Blanchet JP, Rohrschneider LR and Mouchiroud G. . 1998 EMBO J. 17: 7273–7281. · DOI
- Bowtell D, Fu P, Simon M and Senior P. . 1992 Proc. Natl. Acad. Sci. USA 89: 6511–6515. · DOI
- Brugge JS. . 1993 Science 260: 918–919. · DOI
- Buday L and Downward J. . 1993 Cell 73: 611–620. · DOI
- Buday L. . 1999 Biochim. Biophys. Acta 1422: 187–204. · DOI
- Carlier MF, Nioche P, Broutin-L'Hermite I, Boujemaa R, Le Clainche C, Egile C, Garbay C, Ducruix A, Sansonetti P and Pantaloni D. . 2000 J. Biol. Chem. 275: 21946–21952. · DOI
- Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH and Bar-Sagi D. . 1993 Science 260: 1338–1343. · DOI
- Chardin P, Cussac D, Maignan S and Ducruix A. . 1995 FEBS Lett. 369: 47–51. · DOI
- Cheng AM, Saxton TM, Sakai R, Kulkarni S, Mbamalu G, Vogel W, Tortorice CG, Cardiff RD, Cross JC, Muller WJ and Pawson T. . 1998 Cell 95: 793–803. · DOI
- Chien CT, Bartel PL, Sternglanz R and Fields S. . 1991 Proc. Natl. Acad. Sci. USA 88: 9578–9582. · DOI
- Clark SG, Stern MJ and Horvitz HR. . 1992 Nature 356: 340–344. · DOI
- Clements JL, Boerth NJ, Lee JR and Koretzky GA. . 1999 Annu. Rev. Immunol. 17: 89–108. · DOI
- Cowburn D, Zheng J, Xu Q and Barany G. . 1995 J. Biol. Chem. 270: 26738–26741. · DOI
- Cussac D, Vidal M, Leprince C, Liu WQ, Cornille F, Tiraboschi G, Roques BP and Garbay C. . 1999 FASEB J. 13: 31–38. · DOI
- den Hertog J and Hunter T. . 1996 EMBO J. 15: 3016–3027. · DOI
- Donovan JA, Wange RL, Langdon WY and Samelson LE. . 1994 J. Biol. Chem. 269: 22921–22924. · DOI
- Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM and Weinberg RA. . 1993 Nature 363: 45–51. · DOI
- Eijkelenboom AP, Lutzke RA, Boelens R, Plasterk RH, Kaptein R and Hard K. . 1995 Nat. Struct. Biol. 2: 807–810. · DOI
- Ellis JH, Ashman C, Burden MN, Kilpatrick KE, Morse MA and Hamblin PA. . 2000 J. Immunol. 164: 5805–5814. · DOI
- Feller SM, Knudsen B, Wong TW and Hanafusa H. . 1995b Meth. Enzymol. 255: 369–378. · DOI
- Feng GS, Ouyang YB, Hu DP, Shi ZQ, Gentz R.and Ni J. . 1996 J. Biol. Chem. 271: 12129–12132. · DOI
- Fixman ED, Holgado-Madruga M, Nguyen L, Kamikura DM, Fournier TM, Wong AJ and Park M. . 1997 J. Biol. Chem. 272: 20167–20172. · DOI
- Fu S, Waha A and Vogt PK. . 2000 Oncogene 19: 3537–3545. · DOI
- Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE and Band H. . 1995 J. Biol. Chem. 270: 19141–19150. · DOI
- Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J and Bar-Sagi D. . 1993 Nature 363: 88–92. · DOI
- Gorina S and Pavletich NP. . 1996 Science 274: 1001–1005. · DOI
- Goudreau N, Cornille F, Duchesne M, Parker F, Tocque B, Garbay C and Roques BP. . 1994 Nat. Struct. Biol. 1: 898–907. · DOI
- Hildt E and Oess S. . 1999 J. Exp. Med. 189: 1707–1714. · DOI
- Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK and Wong AJ. . 1996 Nature 379: 560–564. · DOI
- Jackman JK, Motto DG, Sun Q, Tanemoto M, Turck CW, Peltz GA, Koretzky GA and Findell PR. . 1995 J. Biol. Chem. 270: 7029–7032. · DOI
- Kang H, Freund C, Duke-Cohan JS, Musacchio A, Wagner G and Rudd CE. . 2000 EMBO J. 19: 2889–2899. · DOI
- Kardinal C, Konkol B, Schulz A, Posern G, Lin H, Adermann K, Eulitz M, Estrov Z, Talpaz M, Arlinghaus RB and Feller SM. . 2000 FASEB J. 14: 1529–1538. · DOI
- Kim HH, Tharayil M and Rudd CE. . 1998 J. Biol. Chem. 273: 296–301. · DOI
- Kishan RKV, Scita G, Wong WT, Di Fiori PP and Newcomer ME. . (1997) Nature Struct. Biol. 4: 739–743. · DOI
- Knudsen BS, Zheng J, Feller SM, Mayer JP, Burrell SK, Cowburn D and Hanafusa H. . 1995 EMBO J. 14: 2191–2198. · DOI
- Kohda D, Terasawa H, Ichikawa S, Ogura K, Hatanaka H, Mandiyan V, Ullrich A, Schlessinger J and Inagaki F. . 1994 Structure 2: 1029–1040. · DOI
- Law CL, Ewings MK, Chaudhary PM, Solow SA, Yun TJ, Marshall AJ, Hood L and Clark EA. . 1999 J. Exp. Med. 189: 1243–1253. · DOI
- Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B and Schlessinger J. . 1993 Nature 363: 85–88. · DOI
- Liu SK and McGlade CJ. . 1998 Oncogene 17: 3073–3082. · DOI
- Liu SK, Fang N, Koretzky GA and McGlade CJ. . 1999 Curr. Biol. 9: 67–75. · DOI
- Liu SK, Smith CA, Arnold R, Kiefer F and McGlade CJ. . 2000 J. Immunol. 165: 1417–1426. · DOI
- Lock LS, Royal I, Naujokas MA and Park M. . (2000) J. Biol. Chem. 275: 31536–31545. · DOI · Paper page
- Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D and Schlessinger J. . 1992 Cell 70: 431–442. · DOI
- Lupher Jr ML, Rao N, Eck MJ and Band H. . 1999 Immunol. Today 20: 375–382. · DOI
- Mongiovi AM, Romano PR, Panni S, Mendoza M, Wong WT, Musacchio A, Cesareni G and Di Fiore PP. . 1999 EMBO J. 18: 5300–5309. · DOI
- Motto DG, Ross SE, Wu J, Hendricks-Taylor LR and Koretzky GA. . 1996 J. Exp. Med. 183: 1937–1943. · DOI
- Nguyen JT, Turck CW, Cohen FE, Zuckermann RN and Lim WA. . 1998 Science 282: 2088–2092. · DOI
- Nguyen JT, Porter M, Amoui M, Miller WT, Zuckermann RN and Lim WA. . 2000 Chem. Biol. 7: 463–473. · DOI
- Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y and Hirai H. . 1995 J. Biol. Chem. 270: 10800–10805. · DOI
- Oehrl W, Kardinal C, Ruf S, Adermann K, Groffen J, Feng GS, Blenis J, Tan TH and Feller SM. . 1998 Oncogene 17: 1893–1901. · DOI
- Okkenhaug K and Rottapel R. . 1998 J. Biol. Chem. 273: 21194–21202. · DOI
- Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tam C, Scharenberg AM, Kinet JP and Witte ON. . 1996 Immunity 4: 515–525. · DOI
- Park RK, Kyono WT, Liu Y and Durden DL. . 1998 J. Immunol. 160: 5018–5027. · DOI
- Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J and Gishizky ML. . 1993 Cell 75: 175–185. · DOI
- Pomerance M, Multon MC, Parker F, Venot C, Blondeau JP, Tocque B and Schweighoffer F. . 1998 J. Biol. Chem. 273: 24301–24304. · DOI
- Posern G, Zheng J, Knudsen BS, Kardinal C, Muller KB, Voss J, Shishido T, Cowburn D, Cheng G, Wang B, Kruh GD, Burrell SK, Jacobson CA, Lenz DM, Zamborelli TJ, Adermann K, Hanafusa H and Feller SM. . 1998 Oncogene 16: 1903–1912. · DOI
- Qiu M, Hua S, Agrawal M, Li G, Cai J, Chan E, Zhou H, Luo Y and Liu M. . 1998 Biochem. Biophys. Res. Commun. 253: 443–447. · DOI
- Reuther GW and Der CJ. . 2000 Curr. Opin. Cell. Biol. 12: 157–165. · DOI
- Robinson MJ and Cobb MH. . 1997 Curr. Opin. Cell. Biol. 9: 180–186. · DOI
- Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG et al. 1992 Nature 360: 689–692. · DOI
- Rozakis-Adcock M, Fernley R, Wade J, Pawson T and Bowtell D. . 1993 Nature 363: 83–85. · DOI
- Schaeper U, Gehring NH, Fuchs KP, Sachs M, Kempkes B and Birchmeier W. . 2000 J. Cell. Biol. 149: 1419–1432. · DOI
- Simon MA, Dodson GS and Rubin GM. . 1993 Cell 73: 169–177. · DOI
- Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA and Kay BK. . 1996 Proc. Natl. Acad. Sci. USA 93: 1540–1544. · DOI
- Takenawa T, Miki H and Matuoka K. . 1998 Curr. Top. Microbiol. Immunol. 228: 325–342. · DOI
- Tanaka N, Kaneko K, Asao H, Kasai H, Endo Y, Fujita T, Takeshita T and Sugamura K. . 1999 J. Biol. Chem. 274: 19129–19135. · DOI
- Terasawa H, Kohda D, Hatanaka H, Tsuchiya S, Ogura K, Nagata K, Ishii S, Mandiyan V, Ullrich A, Schlessinger J et al. 1994 Nat. Struct. Biol. 1: 891–897. · DOI
- Trenkle T, McClelland M, Adlkofer K and Welsh J. . 2000 Gene 245: 139–149. · DOI
- Whisstock JC and Lesk AM. . 1999 Trends Biochem. Sci. 24: 132–133. · DOI
- Xu XX, Yi T, Tang B and Lambeth JD. . 1998 Oncogene 16: 1561–1569. · DOI
Cited by
Sorted by citations
Systems-level interactions between insulin–EGF networks amplify mitogenic signaling
Borisov, N., Aksamitiene, E., Kiyatkin, A., Legewie, S., Berkhout, J., Maiwald, T., Kaimachnikov, N. P., Timmer, J., Hoek, J. B., & Kholodenko, B. N. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.19 · Cited by 222
Berlin, I., Schwartz, H., & Nash, P. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016287 · Cited by 121
Conformational Recognition of an Intrinsically Disordered Protein
Krieger, J. M., Fusco, G., Lewitzky, M., Simister, P. C., Marchant, J., Camilloni, C., Feller, S. M., & De Simone, A. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.03.004 · Cited by 56
Self-citationStructural and mechanistic insights into the constitutive Themis–Grb2 complex in T cell signalling
Clancy, D. M., Sanz-Sanjuan, A., Gilis, E., Tougaard, P., Velghe, I., Van Droogenbroeck, Y., Felix, J., Bloch, Y., Cuadrado, Á. F., Merceron, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73359-8
Metadata
- Authors
- Lewitzky, M., Kardinal, C., Gehring, N. H., Schmidt, E. K., Konkol, B., Eulitz, M., Birchmeier, W., Schaeper, U., & Feller, S. M.
- Venue
- Oncogene
- Published
- 2001-03-01
- Volume
- 20
- Issue
- 9
- Pages
- 1052-1062
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 95
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review